USE OF HIGH-DOSE OXAZAPHOSPHORINE DRUGS FOR TREATING IMMUNE DISORDERS

摘要

This disclosure relates, at least in part, to methods of eliminating adverse immune reactions in a subject in need thereof including those associated wit h autoimmune diseases, allergic reactions and transplant rejection, including administration of a lymphocytotoxic non-myeloablative amount of a oxazaphosphorine drug to the subject.